[{"id":"8bea9c3c-197e-4706-b191-0d2571fb7a6a","acronym":"","url":"https://clinicaltrials.gov/study/NCT00071071","created_at":"2021-01-18T00:10:54.068Z","updated_at":"2024-07-02T16:35:47.645Z","phase":"Phase 2","brief_title":"Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.","source_id_and_acronym":"NCT00071071","lead_sponsor":"Genmab","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HuMax-CD4 (zanolimumab)"],"overall_status":"Completed","enrollment":" Enrollment 25","initiation":"Initiation: 04/30/2003","start_date":" 04/30/2003","primary_txt":" Primary completion: 05/05/2004","primary_completion_date":" 05/05/2004","study_txt":" Completion: 05/05/2004","study_completion_date":" 05/05/2004","last_update_posted":"2023-05-18"},{"id":"da344895-91d1-429d-93bf-0b271ba442a2","acronym":"","url":"https://clinicaltrials.gov/study/NCT00071084","created_at":"2021-01-18T00:10:54.267Z","updated_at":"2024-07-02T16:35:49.352Z","phase":"Phase 2","brief_title":"Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.","source_id_and_acronym":"NCT00071084","lead_sponsor":"Genmab","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HuMax-CD4 (zanolimumab)"],"overall_status":"Completed","enrollment":" Enrollment 22","initiation":"Initiation: 05/27/2003","start_date":" 05/27/2003","primary_txt":" Primary completion: 06/29/2004","primary_completion_date":" 06/29/2004","study_txt":" Completion: 06/29/2004","study_completion_date":" 06/29/2004","last_update_posted":"2023-04-28"}]